NCT00955786
- Conditions
- Advanced Solid Tumors, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Scottsdale, Arizona, United States
- San Antonio, Texas, United States
Clinical trial condition
Advanced Solid Tumors
Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.
609 public trials
183 recruiting studies
Advanced Solid Tumors trial results
NCT00881244
- Conditions
- Advanced Solid Tumors
- Locations
-
- James Graham Brown Cancer Center, University of Louisville Louisville, Kentucky, United States
NCT00116896
- Conditions
- Advanced Solid Tumors
- Locations
-
- Vanderbilt Universtiy Medical Center Nashville, Tennessee, United States
- Institute for Drug DevelopmentCancer Therapy & Research Center San Antonio, Texas, United States
NCT00712504
- Conditions
- Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
- Locations
-
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Birmingham, Alabama, United States
- Pfizer Investigational Site Nashville, Tennessee, United States
Active, Not Recruiting
Rollover Study for Continued Safety and Tolerability in Subjects Treated With Spartalizumab Alone or in Combination With Other Study Treatments
NCT04058756
- Conditions
- Advanced Solid Tumors
- Locations
-
- Columbia University Medical Center New York, United States
- Providence Portland Medical Center Portland, Oregon, United States
- MD Anderson Cancer Center Uni of Te Houston, Texas, United States
- Novartis Investigative Site Leuven, Belgium
Active, Not Recruiting
A Trial of Belzutifan (PT2977, MK-6482) Tablets In Patients With Advanced Solid Tumors (MK-6482-001)
NCT02974738
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Astrocytoma, +39 more
- Locations
-
Not specified
Active, Not Recruiting
Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)
NCT05853367
- Conditions
- Advanced Solid Tumors, Metastatic Solid Tumors, Parkinson Disease 4, Autosomal Dominant Lewy Body
- Locations
-
- Northwestern Memorial Hospital ( Site 0002) Chicago, Illinois, United States
- The University of Louisville, James Graham Brown Cancer Center ( Site 0004) Louisville, Kentucky, United States
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001) Hackensack, New Jersey, United States
- Rutgers Cancer Institute of New Jersey ( Site 0005) New Brunswick, New Jersey, United States
Active, Not Recruiting
A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
NCT05114759
- Conditions
- Advanced Solid Tumors
- Locations
-
- Chongqing Cancer Hospital Chongqicun, Chongqi, China
- Fujian Provincial Cancer Hospital Fuzhou, Fujian, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- Hunan Cancer Hospital Changsha, Hunan, China
Active, Not Recruiting
An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors
NCT06076291
- Conditions
- Advanced Solid Tumors
- Locations
-
- The Affiliated Hospital of USTC Hefei, Anhui, China
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Henan Cancer Hospital Zhenzhou, Henan, China
- The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan, China
NCT05614102
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +31 more
- Locations
-
- Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's Denver, Colorado, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
- START | San Antonio San Antonio, Texas, United States
- Antwerp University Hospital | Oncology Department Antwerp, Belgium